scispace - formally typeset
E

Elizabeth M. Graham

Researcher at St Thomas' Hospital

Publications -  121
Citations -  4838

Elizabeth M. Graham is an academic researcher from St Thomas' Hospital. The author has contributed to research in topics: Retinal vasculitis & Uveitis. The author has an hindex of 33, co-authored 121 publications receiving 4434 citations. Previous affiliations of Elizabeth M. Graham include Moorfields Eye Hospital.

Papers
More filters
Journal ArticleDOI

Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases.

TL;DR: The outcome of endogenous bacterial endophthalmitis has not improved in 55 years and clinicians need to have a high level of awareness of this commonly misdiagnosed condition.
Journal ArticleDOI

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

TL;DR: Complete anatomic and, to some extent, functional recovery can be induced by intravitreal TA despite long-term refractory inflammatory CME, and optical coherence tomography aids in the management of these cases.
Journal ArticleDOI

Systemic corticosteroid therapy—side effects and their management

TL;DR: Advice to patients is the key to the safe use of long term systemic corticosteroids and it recommends discussing the following points with the patient: not to stop taking cortiosteroids suddenly to see a doctor if they become unwell, and to read and keep the patient information leaflet to always carry the steroid treatment card.
Journal ArticleDOI

Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis.

TL;DR: In this paper, the authors compared OCT with fundus fluorescein angiography (FFA) for the detection of cystoid macular edema (CME) in patients with uveitis.
Journal ArticleDOI

An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood.

TL;DR: It is possible to characterise the severity of those with childhood chronic anterior uveitis at the onset of disease, and it may be possible to reduce the complication rate by targeting aggressive immunosuppression on high risk patients before complications develop.